Synthetic peptide studied for growth hormone signaling and metabolic research applications.
$100.00
A synthetic GHRH analog, structurally stabilized for a longer half-life than natural GHRH.
FDA-approved specifically to reduce excess abdominal fat (lipodystrophy) in HIV patients on antiretroviral therapy.
Reductions in visceral adipose tissue and modest increases in IGF-1 in approved clinical use.
FDA-approved for a narrow indication. Off-label use for general fat loss or anti-aging is common but unapproved and unstudied for that purpose.
